Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MTPS9579A in asthma patients requiring inhaled corticosteroids and a second controller has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MTPS9579A

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2023-08-14